CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 77 filers reported holding CYTOMX THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 2.44 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $334 | -98.3% | 259 | -98.0% | 0.00% | – |
Q1 2023 | $19,706 | -78.1% | 13,050 | -76.8% | 0.00% | – |
Q4 2022 | $90,050 | +23.4% | 56,281 | +11.3% | 0.00% | – |
Q3 2022 | $73,000 | -28.4% | 50,586 | -9.4% | 0.00% | -100.0% |
Q2 2022 | $102,000 | -11.3% | 55,846 | +208.5% | 0.00% | 0.0% |
Q2 2021 | $115,000 | – | 18,101 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 5,803,700 | $25,130,000 | 0.91% |
Altium Capital Management LP | 663,800 | $2,874,000 | 0.79% |
Rubric Capital Management LP | 2,406,449 | $10,420,000 | 0.49% |
RTW INVESTMENTS, LP | 6,029,700 | $26,109,000 | 0.38% |
Orbimed Advisors | 3,214,509 | $13,919,000 | 0.18% |
TANG CAPITAL MANAGEMENT LLC | 152,345 | $660,000 | 0.13% |
PLATINUM INVESTMENT MANAGEMENT LTD | 980,085 | $4,244,000 | 0.12% |
Point72 Asset Management, L.P. | 6,303,025 | $27,292,000 | 0.11% |
Sender Co & Partners, Inc. | 40,720 | $176,000 | 0.09% |
Manteio Capital LLC | 15,067 | $65,000 | 0.08% |